Skip to content

Study on the efficacy of whitening agent that combines protective and whitening agent

Clinical Efficacy of Self-Bleaching Agent Combining Primer and Patch

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004625
Enrollment
112
Registered
2020-01-14
Start date
2019-03-04
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : - Drugs: hydrogen peroxide - Capacity: 3.0&#37
- Number of times: once / day - Duration: 10 days - Injection route: Remove the patch containing the chemicals on the tooth surface - 30 minutes placebo control group, 30 minutes experiment group, 60

Sponsors

Kyungpook National University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: * Inclusion * - Adults over 20 years of age who agree to participate in the test - Have good general health and oral health - Person with six maxillary anterior teeth - People who have a proper level of discoloration of teeth and similar degree of discoloration of each tooth - A person who understands the purpose of the test and who can read and write - A person who can follow the test procedure well and follow the visit schedule - Who can be followed during the test

Exclusion criteria

Exclusion criteria: * Exclusion * - People with inadequate dentition in the practice of teeth whitening - Resin and porcelain restoration in the anterior region - Inflammation of the pulp due to dental caries or tooth abrasion - People with hypersensitivity due to gingivitis and periodontitis - People with excessive discoloration due to medication and birth defects - Haven't had teeth whitening in the past 3 years - Women who are pregnant, lactating or planning pregnancy during the trial - There are other diseases or administration of the drug that may affect the efficacy or safety evaluation of the drug - Participants in other clinical or human trials - Others unable to communicate or have difficulty following instructions - Others who are not suitable for the examination under the judgment of the person in charge of the examination

Design outcomes

Primary

MeasureTime frame
Efficacy - delta L, a, b, E;Efficacy - National Bureau of Standards (NBS) unit

Secondary

MeasureTime frame
Safety - Gingival index, tooth sensitivity, gingival irritation;Safety - Tooth sensitivity;Safety - Gingival irritation

Countries

Korea, Republic of

Contacts

Public ContactKim Kyoung

Kyungpook National University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026